Literature DB >> 10896366

Pars plana vitrectomy in diabetic macular edema.

T Micelli Ferrari1, N Cardascia, G Durante, M Vetrugno, L Cardia.   

Abstract

PURPOSE: To ascertain the association between the improvement of diabetic macular edema and increased visual acuity after pars plana vitrectomy.
METHODS: From January 1994 to December 1996 we prospectively studied 18 patients (18 eyes, 7 women and 11 men, mean age 52 years, range 37-68) with type II diabetes and clinically significant macular edema. One group was composed of 9 patients presenting diffuse macular edema (DME); a second group with 9 patients presented cystoid macular edema (CME). All patients underwent pars plana vitrectomy.
RESULTS: Preoperative Snellen visual acuity was 20/143 in DME and 20/441 in CME. In both groups vision increased to 20/136 and 20/205, respectively, postoperatively. For the DME this difference was statistically significant (p<0.05) at 1 month after the surgery, but vision decreased again after 10 months reaching preoperative values.
CONCLUSIONS: Our results suggest that pars plana vitrectomy for diabetic macular edema may increase visual acuity in diffuse macular edema, although this increase is only short lived.

Entities:  

Mesh:

Year:  1999        PMID: 10896366     DOI: 10.1023/a:1002464307469

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  4 in total

1.  Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction.

Authors:  H Lewis; G W Abrams; M S Blumenkranz; R V Campo
Journal:  Ophthalmology       Date:  1992-05       Impact factor: 12.079

2.  Vitrectomy for diffuse macular edema in cases of diabetic retinopathy.

Authors:  N Tachi; N Ogino
Journal:  Am J Ophthalmol       Date:  1996-08       Impact factor: 5.258

3.  Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus.

Authors:  T Hikichi; N Fujio; J Akiba; Y Azuma; M Takahashi; A Yoshida
Journal:  Ophthalmology       Date:  1997-03       Impact factor: 12.079

4.  Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane.

Authors:  J W Harbour; W E Smiddy; H W Flynn; P E Rubsamen
Journal:  Am J Ophthalmol       Date:  1996-04       Impact factor: 5.258

  4 in total
  9 in total

1.  Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.

Authors:  Brett J Rosenblatt; Gaurav K Shah; Sanjay Sharma; Jeff Bakal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-31       Impact factor: 3.117

2.  A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema.

Authors:  D Thomas; C Bunce; C Moorman; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

3.  Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study.

Authors:  S P Shah; M Patel; D Thomas; S Aldington; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

4.  Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.

Authors:  Julia A Haller; Haijing Qin; Rajendra S Apte; Roy R Beck; Neil M Bressler; David J Browning; Ronald P Danis; Adam R Glassman; Joseph M Googe; Craig Kollman; Andreas K Lauer; Mark A Peters; Margaret E Stockman
Journal:  Ophthalmology       Date:  2010-03-17       Impact factor: 12.079

Review 5.  [Diabetic maculopathy].

Authors:  C Haritoglou; M Kernt; A Wolf
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

6.  Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes.

Authors:  Norihito Doi; Taiji Sakamoto; Yasushi Sonoda; Miho Yasuda; Koji Yonemoto; Noboru Arimura; Eisuke Uchino; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-19       Impact factor: 3.117

7.  Recurrence of diabetic macular edema after intravitreous injection of triamcinolone following vitrectomy.

Authors:  Yuka Shimonagano; Norihito Doi; Yoshihiro Noda; Akinori Uemura; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2007-08-03       Impact factor: 2.447

8.  Triamcinolone versus inner-limiting membrane peeling in persistent diabetic macular edema (TIME study): design issues and implications.

Authors:  Antonia M Joussen; Claudia Weiss; Diana Bauer; Ralf-Dieter Hilgers
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-26       Impact factor: 3.117

9.  Results of visual acuity and foveal thickness in diabetic macular edema after vitrectomy.

Authors:  Yuka Shimonagano; Reiko Makiuchi; Miho Miyazaki; Norihito Doi; Akinori Uemura; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2007-06-07       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.